Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
879 participants
INTERVENTIONAL
2014-10-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Subjects
NCT02222896
Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Volunteers
NCT02526667
Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth
NCT02224625
Pre-operative Preparation Using 2% Chlorhexidine Cloth For Shoulder Surgery
NCT01090479
Eliminate Risk of Cardiac Surgical Site Events
NCT01425697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chlorhexidine Gluconate Cloth
2% CHG, single application
Chlorhexidine Gluconate
comparison with other CHG products
Vehicle Cloth
Excipients on cloth
Vehicle
Excipients of CHG product only.
Active Chlorhexidine gluconate solution
Dynahex 2% CHG
DynaHex-2
2% CHG solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chlorhexidine Gluconate
comparison with other CHG products
Vehicle
Excipients of CHG product only.
DynaHex-2
2% CHG solution
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 16 years of age or older
* Signed informed consent
* Good Health
* Six inches of abdomen and groin areas without tattoos, or skin disorders
Exclusion Criteria
* Sensitivity to latex
* Sensitivity to CHG
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medline Industries
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
C Beausoleil
Role: PRINCIPAL_INVESTIGATOR
BS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BioScience
Butte, Montana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R13-052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.